in

Xultophy 100/3.6 (Insulin Degludec and Liraglutide) for Obese Diabetics

Xultophy Insulin

xultophy benefits

Xultophy injection is a combination of two antidiabetic medications. It contains Insulin degludec and liraglutide. Insulin Degludec is an ultra long-acting insulin while liraglutide is a GLP-1 analog.

Xultophy pen is available as 100/3.6 mg per ml pen. One ml of Xultophy pen contains 100 units of insulin Degludec and 3.6 mg of liraglutide. Liraglutide is also available alone by the brand name of Victoza and Saxenda.

Liraglutide or Victoza is a GLP-1 analog that was primarily launched for the treatment of obesity. However, because of its excellent anti-diabetic efficacy, it is now commonly used to treat patients with diabetes who are obese.

Liraglutide is indicated for the treatment of Diabetes and Obesity

Insulin Degludec is an ultra-long-acting anti-diabetic medicine that is used to treat patients with diabetes. Because of its ultra-long half-life, it is used as a once-daily injection to provide basal insulin coverage. It is best to use it in patients who have uncontrolled pre-meals or fasting blood sugars.

Compared to insulin glargine, it can be administered at any time of the day. The time schedule can be changed as well. For example, it can be administered after dinner on one day and at noon the next day.

Insulin Degludec (Tresiba) Dose, Class, Brands, Side effects, Conversion

Starting dose of Xultophy injection:

It is initially given as 10 units that contain 10 mg of insulin Degludec and 0.36 mg of liraglutide. The dose may be increased gradually to achieve the target blood sugars.

xultophy benefits

What are the benefits of Xultophy injection?

Apart from the antidiabetic effects of Insulin Degludec and Liraglutide, the combination offers the following advantages:

  • Single Injection:

    • Both the liraglutide and insulin Degludec are injectable medications. Their combination in the form of Xultophy, provides the ease of a single injection. This reduces the number of pricks and is more patient-friendly.
  • Weight-neutral effect:

    • Insulin, including insulin Degludec may cause weight gain. On the other hand, liraglutide induces weight loss. The combination is thus used in patients who are prone to gain weight with insulin. It may induce some weight loss as well.
  • Xultophy is less costly:

    • Victoza or liraglutide injection costs around PKR of 40000 per month. Similarly, insulin Degludec will add further to the cost if given as a separate injection.
    • One injection of Xultophy in Pakistan costs around PKR 7000. The overall cost is much less than the cost of individual medicine.

Tresiba to Lantus Conversion Guidelines: Calculate Your Dose

Who should not use injection Xultophy?

It is important to note that some patients might be allergic to either insulin Degludec or liraglutide and should avoid Xultophy.

It is also contraindicated in pregnant women and in acutely ill patients. Patients with an acute hyperglycemic crisis should avoid Xultophy.

Tresiba Vs Lantus (Degludec Vs Glargine) Comparison

GLP-1 analogs including liraglutide are also contraindicated in patients with medullary thyroid carcinoma including patients with a past history or those with a family history of medullary thyroid carcinoma. Individuals with multiple endocrine neoplasia type 2 (MEN II) should also avoid using this drug.

It should be used with extreme caution in patients with pancreatic diseases or disease of the gall bladder. Lastly, intramuscular or intravenous administration of the drug should be avoided.

Xultophy Dosing Chart is published here: Xultophy Dosing Chart

What do you think?

Written by Diabetes Doctor

I am an Internist practicing medicine for the last fifteen years. Over the years, I have learned that medicine is not about prescribing pills. True medical practice is helping people.
I do prescribe pills as well but the best results I get are when I motivate people to overcome their problems with little changes in their lifestyles.
Since most of my patients are obese, have diabetes, hypertension, high cholesterol levels, I am writing at dibesity.com when free.
Dibesity, I know the correct word is diabesity. Ignore this! Be with us.

Leave a Reply

liraglutide mechanism of action moa for diabetes and obesity

Liraglutide Mechanism of Action for Weight Loss (Obesity) and Diabetes

Rapid Acting Insulin (Fast acting Insulin or Ultra-Short acting Insulin)